Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Change in Receivables (2024 - 2025)

Profound Medical has reported Change in Receivables over the past 2 years, most recently at -$736000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$736000.0 for Q4 2025, down 223.7% from a year ago — trailing twelve months through Dec 2025 was $172000.0 (up 192.47% YoY), and the annual figure for FY2025 was $172000.0, up 192.47%.
  • Change in Receivables for Q4 2025 was -$736000.0 at Profound Medical, down from $3.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for PROF hit a ceiling of $3.4 million in Q3 2025 and a floor of -$1.4 million in Q2 2025.